Category: Prescription Drugs

Recent Key Developments are Major Turning Points in Health Policy

Earlier this month, all eyes were on two major events in the federal health policy world: the outcome of the election and the Supreme Court’s decision in California v. Texas. ...

Health Policy News – January 2020

Introduction Happy 2020 Health Policy News readers! We hope you all had an enjoyable and relaxing holiday season. As we continue to await the proposed Marketplace guidance for 2021, we ...

California’s Innovative Approach to Address Rising Pharmaceutical Costs

Addressing rising prescription drug costs has been a top priority for California Governor Gavin Newsom’s administration. Health Policy News reported early in his term about the Governor’s Executive Order that ...

Health Policy News – December 2019

Health Policy News is once again dedicating our December edition to reflecting on the past year’s high-profile healthcare topics—providing context, summarizing recent developments, and predicting what activity is in store ...

2020 Prediction: Continued Focus on Ensuring Access to Healthcare, Prescription Drugs, and Healthy Food to Combat Diet-Related Illness

Over the past year, Health Policy News readers were drawn to topics that were top of mind for many policymakers, as well as articles that detailed innovative solutions to complex ...

Highlights from The Workers Compensation Research Institute 2019 Annual Issues and Research Conference

February 28-March 1, 2019, marked the 35th annual Workers Compensation Research Institute (WCRI) Issues and Research Conference. The theme of this year’s event, “Breaking Down Barriers to Improve Injured Workers’ ...

2019 Brings Progress on Prescription Drug Cost Control Efforts at State and Federal Level

As states and the federal government grapple with how best to address the issue of rising prescription drug costs, various models have emerged at the federal level that are similar ...

1115 Waiver Decisions issued by CMS

As we addressed in our report this past Spring, the use of Section 1115 Medicaid Waivers to address rising drug costs was a notable feature of the Federal administration’s recent ...